Cyclin D1 overexpression correlates with poor prognosis in patients with tongue squamous cell carcinoma

Oral Oncology

Volumn 36, Issue 2, 2000, Pages 194-198

  Mineta, H ^a   Miura, K ^b   Takebayashi, S ^a   Ueda, Y ^a   Misawa, K ^a   Harada, H ^b   Wennerberg, J ^c   Dictor, M ^c  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HAMAMATSU UNIVERSITY HOSPITAL   (Japan)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cyclin D1; Immunohistochemistry; Prognosis; Tongue cancer

Indexed keywords

CYCLIN D1;

ADOLESCENT; ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SEX; SMOKING; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TONGUE CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; CARCINOMA, SQUAMOUS CELL; CYCLIN D1; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; JAPAN; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; SMOKING; SURVIVAL ANALYSIS; TONGUE NEOPLASMS;

EID: 0034162037     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(99)00078-0     Document Type: Article

References (17)

1. Renan, M.J. How many mutations are required for tumorigenesis? Implications from human cancer data. Mol Carcinogenesis 1993;7:139-46.
2. Kastan M.B. Molecular biology of cancer: the cell cycle. DeVita V.T., Hellman S., Rosenberg S.A. Cancer: principles and practice of oncology. 1997;121-134 Lippincott-Raven, Philadelphia.
3. Michalides R., van Veelen N., Hart A., Loftus B., Wientjens E., Balm A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res. 55:1995;975-978.
4. Masuda M., Hirakawa N., Nakashima T., Kuratomi Y., Komiyama S. Cyclin D1 overexpression in primary hypopharyngeal carcinomas. Cancer. 78:1996;390-395.
5. Mineta H., Borg Å., Dictor M., Wahlberg P., Wennerberg J. Correlation between p53 mutation and cyclin D1 amplification in head and neck squamous cell carcinoma. Eur J Cancer. 33(B):1997;42-46.
6. Chen X., Bargonetti J., Prives C. P53, through p21(WAF1/CIP1), induces cyclin D1 synthesis. Cancer Res. 55:1995;4257-4263.
7. Sidransky D. Cancer of the head and neck. Molecular biology of head and neck tumors. DeVita V.T. Jr., Hellman S., Rosenberg S.A. Cancer: principles and practice of oncology. 1997;735-740 Lippincott-Raven, Philadelphia.
8. Sobin LH, Witterkind Ch, editors. TNM classification of malignant tumours. New York: Wiley-Liss, 1997. p. 17-50.
9. Mineta H., Borg Å., Dictor M., Wahlberg P., Åkervall J., Wennerberg J. P53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma. Br J Cancer. 78:1998;1084-1090.
10. Gansauge S., Gansauge F., Ramadani M., Stobbe H., Rau B., Harada N., Beger H.G. Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis. Cancer Res. 57:1997;1634-1637.
11. Bartkova J., Lukas J., Müller H., Lützhóft D., Straus M., Bartek J. Cyclin D1 protein expression and function in human breast cancer. Int J Cancer. 57:1994;353-361.
12. Nikaido T., Li S.-F., Shiozawa T., Fujii S. Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas. Cancer. 78:1996;1248-1253.
13. Lee C.C.R., Yamamoto S., Morimura K., Wanibuchi H., Nishisaka N., Ikemoto S., Nakatani T., Wada S., Kishimoto T., Fukushima S. Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features. Cancer. 79:1997;780-789.
14. Adélaide J., Monges G., Dérdérian, Seiz J.F., Birnbaum D. Esophageal cancer and amplification of the human cyclin D1 gene CCND1/PRAD1. Br J Cancer. 71:1995;64-68.
15. Marx J. How cells cycle toward cancer. Science. 263:1994;319-321.
16. Kotelnikov V.M., Coon 4th J.S., Mundle S., Kelanic S., LaFollette S., Taylor 5th S., Hutchinson J., Panje W., Caldarelli D.D., Preisler H.D. Cyclin D1 expression in squamous cell carcinomas of the head and neck in oral mucosa in relation to proliferation and apoptosis. Clin Cancer Res. 3:1997;95-101.
17. Betticher D.C., Heighway J., Hasleton P.S., Altermatt H.J., Ryder W.D., Cerny N., Thatcher N.N. Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. Br J Cancer. 73:1996;294-300.